<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01171846</url>
  </required_header>
  <id_info>
    <org_study_id>PREVPROL Study RG1271</org_study_id>
    <nct_id>NCT01171846</nct_id>
  </id_info>
  <brief_title>A Study of the Effects of Physiotherapy to Prevent Pelvic Organ Prolapse</brief_title>
  <acronym>PREVPROL</acronym>
  <official_title>A Multicentre Randomised Controlled Trial of Pelvic Floor Muscle Training to Prevent Pelvic Organ Prolapse in Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Glasgow Caledonian University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Birmingham</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Birmingham Women's NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Aberdeen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Aberdeen Royal Infirmary</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Otago</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Glasgow Caledonian University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pelvic organ prolapse is a problem experienced by women where a bulge comes down in the
      vagina, and may even drop down outside the vagina. The bulge in the vagina is caused by other
      organs moving down from their normal position in the pelvis and pushing into the vagina. This
      is a very common problem and many women who have given birth will have a very mild bulge
      which does not cause them symptoms. Women can however experience a variety of pelvic,
      bladder, bowel and sexual symptoms which impact on daily life. No research studies have
      properly examined whether or not exercises can prevent prolapse. This study aims to explore
      whether exercises taught by a physiotherapist can prevent women developing a prolapse which
      requires them to have treatment.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2010</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pelvic organ prolapse symptom score (POP-SS)</measure>
    <time_frame>Baseline (prior to randomisation)</time_frame>
    <description>A summation of responses to seven prolapse symptom questions (range 0-28)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pelvic organ prolapse symptom score (POP-SS)</measure>
    <time_frame>1 Year post randomisation</time_frame>
    <description>A summation of responses to seven prolapse symptom questions (range 0-28)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pelvic organ prolapse symptom score (POP-SS)</measure>
    <time_frame>2 years post randomisation</time_frame>
    <description>A summation of responses to seven prolapse symptom questions (range 0-28)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pelvic organ prolapse symptom score (POP-SS)</measure>
    <time_frame>3 years post randomisation</time_frame>
    <description>A summation of responses to seven prolapse symptom questions (range 0-28)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pelvic organ prolapse symptom score (POP-SS)</measure>
    <time_frame>4 years post randomisation</time_frame>
    <description>A summation of responses to seven prolapse symptom questions (range 0-28)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prolapse-related quality of life</measure>
    <time_frame>Baseline (prior to randomisation)</time_frame>
    <description>Single item scored 0 to 10</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prolapse severity</measure>
    <time_frame>Four years post randomisation</time_frame>
    <description>Pelvic Organ Prolapse Quantification assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lifestyle changes</measure>
    <time_frame>1 year post randomisation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary symptoms</measure>
    <time_frame>Baseline (prior to randomisation)</time_frame>
    <description>ICIQ urinary incontinence short-form</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bowel symptoms</measure>
    <time_frame>Baseline (prior to randomisation)</time_frame>
    <description>ICIQ bowel symptoms module</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sexual symptoms</measure>
    <time_frame>Baseline (prior to randomisation)</time_frame>
    <description>Prolapse Incontinence Sexual Questionnaire - PISQ 12</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>General health status</measure>
    <time_frame>Baseline (prior to randomisation)</time_frame>
    <description>SF-12</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for prolapse treatment</measure>
    <time_frame>1 year post randomisation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The average number of days of prolapse symptoms</measure>
    <time_frame>Baseline (prior to randomisation)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prolapse-related quality of life</measure>
    <time_frame>1 year post randomisation</time_frame>
    <description>Single item scored 0 to 10</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prolapse-related quality of life</measure>
    <time_frame>2 years post randomisation</time_frame>
    <description>Single item scored 0 to 10</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prolapse-related quality of life</measure>
    <time_frame>3 years post randomisation</time_frame>
    <description>Single item scored 0 to 10</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prolapse-related quality of life</measure>
    <time_frame>4 years post of randomisation</time_frame>
    <description>Single item scored 0 to 10</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lifestyle changes</measure>
    <time_frame>2 years post randomisation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lifestyle changes</measure>
    <time_frame>3 years post randomisation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lifestyle changes</measure>
    <time_frame>4 years post randomisation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary symptoms</measure>
    <time_frame>1 year post randomisation</time_frame>
    <description>ICIQ urinary incontinence short-form</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary symptoms</measure>
    <time_frame>2 years post randomisation</time_frame>
    <description>ICIQ urinary incontinence short-form</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary symptoms</measure>
    <time_frame>3 years post randomisation</time_frame>
    <description>ICIQ urinary incontinence short-form</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary symptoms</measure>
    <time_frame>4 years post randomisation</time_frame>
    <description>ICIQ urinary incontinence short-form</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bowel symptoms</measure>
    <time_frame>1 year post randomisation</time_frame>
    <description>ICIQ bowel symptoms module</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bowel symptoms</measure>
    <time_frame>2 years post randomisation</time_frame>
    <description>ICIQ bowel symptoms module</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bowel symptoms</measure>
    <time_frame>3 years post randomisation</time_frame>
    <description>ICIQ bowel symptoms module</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bowel symptoms</measure>
    <time_frame>4 years post randomisation</time_frame>
    <description>ICIQ bowel symptoms module</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sexual symptoms</measure>
    <time_frame>1 year post randomisation</time_frame>
    <description>Prolapse Incontinence Sexual Questionnaire - PISQ 12</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sexual symptoms</measure>
    <time_frame>2 years post randomisation</time_frame>
    <description>Prolapse Incontinence Sexual Questionnaire - PISQ 12</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sexual symptoms</measure>
    <time_frame>3 years post randomisation</time_frame>
    <description>Prolapse Incontinence Sexual Questionnaire - PISQ 12</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sexual symptoms</measure>
    <time_frame>4 years post randomisation</time_frame>
    <description>Prolapse Incontinence Sexual Questionnaire - PISQ 12</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>General health status</measure>
    <time_frame>1 year post randomisation</time_frame>
    <description>Prolapse Incontinence Sexual Questionnaire - PISQ 12</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>General health status</measure>
    <time_frame>2 years post randomisation</time_frame>
    <description>Prolapse Incontinence Sexual Questionnaire - PISQ 12</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>General health status</measure>
    <time_frame>3 years post randomisation</time_frame>
    <description>Prolapse Incontinence Sexual Questionnaire - PISQ 12</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>General health status</measure>
    <time_frame>4 years post randomisation</time_frame>
    <description>Prolapse Incontinence Sexual Questionnaire - PISQ 12</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for prolapse treatment</measure>
    <time_frame>2 years post randomisation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for prolapse treatment</measure>
    <time_frame>3 years post randomisation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for prolapse treatment</measure>
    <time_frame>4 years post randomisation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The average number of days of prolapse symptoms</measure>
    <time_frame>1 year post randomisation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The average number of days of prolapse symptoms</measure>
    <time_frame>2 years post randomisation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The average number of days of prolapse symptoms</measure>
    <time_frame>3 years post randomisation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The average number of days of prolapse symptoms</measure>
    <time_frame>4 years post randomisation</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">337</enrollment>
  <condition>Pelvic Organ Prolapse</condition>
  <arm_group>
    <arm_group_label>Physiotherapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Women allocated to the Control group will only receive, by post, the same Lifestyle Advice Sheet as the intervention group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Pelvic Floor Muscle training</intervention_name>
    <description>Women allocated to the intervention group will have five appointments with a specialist women's health physiotherapist (intervention physiotherapist) over 16 weeks who will prescribe a daily exercise programme and provide a Lifestyle Advice Sheet (focusing on weight loss, constipation, avoidance of heavy lifting, coughing and high-impact exercise) and relevant tailored advice (phase 1).
Thereafter women in the intervention group will be offered Pilates-based classes, including PFMT, as maintenance (phase 2). Classes will be led by a physiotherapist who has undertaken Pilates training and will take place in six week blocks; each woman will be offered two six week blocks over a year. An exercise DVD will be provided for home use. Each woman will be offered a one-to-one review physiotherapy appointment at one and two years after randomisation.</description>
    <arm_group_label>Physiotherapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Women involved in the ProLong study who:

          -  have some evidence of vaginal laxity in any compartment (POP-Q stage I, II or III)

          -  have had no previous treatment for prolapse (surgery, pessary, PFMT)

        Women must be willing to participate in the Trial and to comply with their group
        allocation.

        Exclusion Criteria:

        Women:

          -  with stage 0 or IV prolapse

          -  who have had previous incontinence surgery (except mid-urethral sling operation)

          -  who have had previous formal instruction in PFMT for any diagnosis in preceding five
             years

          -  who are pregnant, or delivered a baby within the last six months

          -  who are unable to comply with PFMT treatment

          -  who are unable to give informed consent
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Prof Hagen, PhD MSc BSc CStat CSci</last_name>
    <role>Principal Investigator</role>
    <affiliation>NMAHP Research Unit</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dunedin School of Medicine</name>
      <address>
        <city>Dunedin</city>
        <zip>9054</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aberdeen Royal Infirmary</name>
      <address>
        <city>Aberdeen</city>
        <state>Aberdeenshire</state>
        <zip>AB25 2ZN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Birmingham Women's Hospital</name>
      <address>
        <city>Edgbaston</city>
        <state>Birmingham</state>
        <zip>B15 2TG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>New Zealand</country>
    <country>United Kingdom</country>
  </location_countries>
  <results_reference>
    <citation>Hagen, S., C. Glazener, D. McClurg, C. Macarthur, P. Herbison, D. Wilson, P. Toozs-Hobson et al.</citation>
  </results_reference>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 6, 2010</study_first_submitted>
  <study_first_submitted_qc>July 28, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 29, 2010</study_first_posted>
  <last_update_submitted>March 16, 2015</last_update_submitted>
  <last_update_submitted_qc>March 16, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 17, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Glasgow Caledonian University</investigator_affiliation>
    <investigator_full_name>Ms Suzanne Hagen</investigator_full_name>
    <investigator_title>Programme Director</investigator_title>
  </responsible_party>
  <keyword>prevention</keyword>
  <keyword>pelvic floor muscle training</keyword>
  <keyword>prolapse symptoms</keyword>
  <keyword>urinary symptoms</keyword>
  <keyword>sexual function</keyword>
  <keyword>randomised controlled trial</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prolapse</mesh_term>
    <mesh_term>Pelvic Organ Prolapse</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

